In lung cancer cells, abrogation of SCD1 gene expression leads to impaired de novo lipid synthesis, a reduced rate of cell proliferation, a loss of anchorage-independent growth and higher rates of ceramide-independent apoptosis [9]. The gene discussed is SCD; the disease is lung cancer.